Skip to main content
. 2021 Nov;157:308–347. doi: 10.1016/j.ejca.2021.07.039

Table 4.

Estimated numbers of new cancer cases and deaths from cancer (thousands), ASRsa (per 100,000) by sex and cancer site in EU-27 for 2020.

Cancer site Incidence
Mortality
Both sexes
Males
Females
Both sexes
Males
Females
Cases % ASR (E) Cum. Risk % Cases % ASR (E) Cum. Risk % Cases % ASR (E) Cum. Risk % Deaths % ASR (E) Cum. Risk % Deaths % ASR (E) Cum. Risk % Deaths % ASR (E) Cum. Risk %
Lip, oral cavity and pharynx 79.9 3.0 17.0 1.11 56.0 3.9 25.6 1.69 23.9 1.9 9.3 0.56 31.8 2.5 6.7 0.40 23.8 3.4 11.0 0.68 8.0 1.4 3.0 0.15
Oesophagus 30.3 1.1 6.4 0.38 23.3 1.6 10.9 0.65 7.0 0.6 2.7 0.15 25.6 2.0 5.4 0.29 19.9 2.8 9.4 0.51 5.8 1.0 2.1 0.10
Stomach 75.4 2.8 15.8 0.78 46.7 3.2 22.4 1.10 28.8 2.3 10.6 0.49 52.1 4.1 10.9 0.48 32.1 4.6 15.7 0.69 19.9 3.6 7.2 0.30
Colorectum 341.4 12.7 71.8 3.65 191.1 13.2 91.6 4.58 150.4 12.2 56.3 2.82 156.1 12.4 32.4 1.27 87.2 12.3 43.1 1.67 68.9 12.4 24.5 0.91
Liver 60.9 2.3 12.8 0.70 41.9 2.9 19.8 1.11 19.0 1.5 7.0 0.32 53.9 4.3 11.3 0.55 36.6 5.2 17.6 0.86 17.3 3.1 6.3 0.27
Gallbladder 7.8 0.3 1.6 0.07 2.7 0.2 1.3 0.06 5.1 0.4 1.9 0.09 5.5 0.4 1.1 0.05 1.8 0.3 0.9 0.04 3.7 0.7 1.3 0.06
Pancreas 94.9 3.5 19.9 0.94 47.1 3.3 22.6 1.12 47.8 3.9 17.5 0.78 89.3 7.1 18.6 0.86 44.7 6.3 21.6 1.03 44.5 8.0 16.2 0.70
Larynx 24.6 0.9 5.2 0.35 21.2 1.5 9.8 0.63 3.5 0.3 1.4 0.09 11.6 0.9 2.4 0.14 10.2 1.4 4.8 0.27 1.3 0.2 0.5 0.03
Lung 318.3 11.9 67.3 3.93 205.3 14.2 97.2 5.30 113.1 9.1 43.9 2.68 257.3 20.4 54.2 2.97 170.6 24.2 81.7 4.14 86.7 15.6 33.2 1.91
Melanoma of skin 106.4 4.0 22.8 1.41 55.4 3.8 26.0 1.50 51.0 4.1 20.8 1.35 16.5 1.3 3.5 0.16 9.5 1.3 4.6 0.21 7.0 1.3 2.6 0.12
Breast 355.5 28.7 142.8 8.85 91.8 16.5 34.1 1.60
Cervix uteri 30.4 2.5 12.8 0.89 13.4 2.4 5.3 0.32
Corpus uteri 73.3 5.9 28.9 1.86 16.8 3.0 6.2 0.29
Ovary 39.4 3.2 15.5 0.94 27.1 4.9 10.3 0.55
Prostate 335.5 23.2 158.7 8.95 69.9 9.9 36.3 0.82
Testis 17.6 1.2 8.0 0.61 0.9 0.1 0.4 0.03
Kidney 86.8 3.2 18.4 1.09 55.2 3.8 25.8 1.52 31.6 2.6 12.1 0.70 34.4 2.7 7.2 0.32 22.2 3.1 10.8 0.47 12.2 2.2 4.4 0.18
Bladder 157.5 5.9 33.1 1.65 121.5 8.4 58.9 2.73 35.9 2.9 13.4 0.67 49.2 3.9 10.1 0.33 37.1 5.3 18.8 0.56 12.0 2.2 4.2 0.13
Brain, central nervous system 43.6 1.6 9.4 0.59 23.8 1.7 11.1 0.71 19.7 1.6 7.8 0.49 34.7 2.8 7.4 0.45 19.4 2.7 9.0 0.55 15.3 2.8 6.0 0.35
Thyroid 57.7 2.2 12.7 0.91 13.7 0.9 6.2 0.44 44.0 3.6 18.9 1.37 4.0 0.3 0.8 0.03 1.6 0.2 0.8 0.03 2.4 0.4 0.9 0.03
Hodgkin lymphoma 12.0 0.4 2.7 0.19 6.9 0.5 3.2 0.22 5.1 0.4 2.2 0.16 2.2 0.2 0.5 0.02 1.3 0.2 0.6 0.03 0.9 0.2 0.3 0.02
Non-Hodgkin lymphoma 86.3 3.2 18.3 1.03 47.9 3.3 22.6 1.25 38.5 3.1 14.8 0.82 34.9 2.8 7.3 0.29 19.3 2.7 9.5 0.37 15.6 2.8 5.6 0.21
Multiple myeloma 35.8 1.3 7.5 0.39 20.1 1.4 9.7 0.48 15.7 1.3 5.9 0.30 23.3 1.8 4.8 0.19 12.5 1.8 6.2 0.23 10.8 1.9 3.9 0.15
Leukaemia 66.6 2.5 14.1 0.75 37.6 2.6 18.0 0.93 29.0 2.3 11.1 0.59 43.4 3.4 9.0 0.35 24.2 3.4 12.0 0.45 19.2 3.5 6.9 0.27
All sites excl. non-melanoma skin 2682.0 568.7 28.20 1444.9 685.2 31.73 1237.0 483.6 25.07 1261.7 263.5 11.38 706.1 344.9 13.94 555.6 204.5 9.05
a

ASR = Age-standardised rates using European standard population 2013, based on estimated number of new cases or deaths.